| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |